{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:42:45Z","timestamp":1775122965004,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMP"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Mechanistic\/Mammalian target of rapamycin (mTOR) orchestrates cellular homeostasis\nby controlling cell growth, proliferation, metabolism, and survival by integrating various growth\nfactors, nutrients and amino acids. Eccentric synchronization of mTOR has been incriminated in\nvarious diseases\/disorders like cancer, neurodegenerative disorders, and diabetes mellitus and its\ncomplications. Recent reports also highlight the role of mTOR in diabetes and its associated complications.\nThis review tries to fathom the role of mTOR signaling in diabetes mellitus and its\ncomplications- diabetic cardiomyopathy, diabetic nephropathy, and diabetic retinopathy and highlights\nmTOR as a putative target for the development of novel anti-diabetic drug candidates.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1874467215666221005123919","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T11:28:26Z","timestamp":1665055706000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fathoming the Role of mTOR in Diabetes Mellitus and its Complications"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2306-3050","authenticated-orcid":true,"family":"Faheem","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Birla Institute of Technology &amp; Science Pilani, Pilani Campus, Pilani-333031, Rajasthan,\nIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanthi","family":"Sivasubrmanian","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher\nEducation and Research (DU), Chennai- 600 116, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref=1","unstructured":"International Diabetes Federation - Facts and figures. Available from https:\/\/idf.org\/aboutdiabetes\/what-is-diabetes\/facts-figures.html#:~:text=Almost%201%20in%202%20(240,living%20with%20type%201%20diabetes"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc19-S002","volume":"42","year":"2019","unstructured":"2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2019. Diabetes Care American Diabetes Association2019,42(S1),S13-S28","journal-title":"Diabetes Care"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1001\/jama.2019.16074","volume":"322","author":"Williams J.","year":"2019","unstructured":"Williams J.; Loeffler M.; Global trends in type 2 diabetes, 2007-2017. JAMA 2019,322(16),1542","journal-title":"JAMA"},{"key":"ref=4","unstructured":"International Diabetes Federation - Complications Available from: https:\/\/www.idf.org\/aboutdiabetes\/complications.html"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"Laplante M.","year":"2009","unstructured":"Laplante M.; Sabatini D.M.; mTOR signaling at a glance. J Cell Sci 2009,122(20),3589-3594","journal-title":"J Cell Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","volume":"110","author":"Kim D.H.","year":"2002","unstructured":"Kim D.H.; Sarbassov D.D.; Ali S.M.; King J.E.; Latek R.R.; Erdjument-Bromage H.; Tempst P.; Sabatini D.M.; mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002,110(2),163-175","journal-title":"Cell"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"15461","DOI":"10.1074\/jbc.C200665200","volume":"278","author":"Nojima H.","year":"2003","unstructured":"Nojima H.; Tokunaga C.; Eguchi S.; Oshiro N.; Hidayat S.; Yoshino K.; Hara K.; Tanaka N.; Avruch J.; Yonezawa K.; The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J Biol Chem 2003,278(18),15461-15464","journal-title":"J Biol Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2009.03.046","volume":"137","author":"Peterson T.R.","year":"2009","unstructured":"Peterson T.R.; Laplante M.; Thoreen C.C.; Sancak Y.; Kang S.A.; Kuehl W.M.; Gray N.S.; Sabatini D.M.; DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 2009,137(5),873-886","journal-title":"Cell"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"Ali S.M.","year":"2004","unstructured":"Ali S.M.; Kim D-H.; Guertin D.A.; Latek R.R.; Erdjument-Bromage H.; Tempst P.; Sabatini D.M.; Sabatini D.M.; Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004,14(14),1296-1302","journal-title":"Curr Biol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"Inoki K.","year":"2002","unstructured":"Inoki K.; Li Y.; Zhu T.; Wu J.; Guan K.L.; TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002,4(9),648-657","journal-title":"Nat Cell Biol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","volume":"25","author":"Sancak Y.","year":"2007","unstructured":"Sancak Y.; Thoreen C.C.; Peterson T.R.; Lindquist R.A.; Kang S.A.; Spooner E.; Carr S.A.; Sabatini D.M.; PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 2007,25(6),903-915","journal-title":"Mol Cell"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.cub.2005.02.053","volume":"15","author":"Long X.","year":"2005","unstructured":"Long X.; Lin Y.; Ortiz-Vega S.; Yonezawa K.; Avruch J.; Rheb binds and regulates the mTOR kinase. Curr Biol 2005,15(8),702-713","journal-title":"Curr Biol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nature02866","volume":"431","author":"Um S.H.","year":"2004","unstructured":"Um S.H.; Frigerio F.; Watanabe M.; Picard F.; Joaquin M.; Sticker M.; Fumagalli S.; Allegrini P.R.; Kozma S.C.; Auwerx J.; Thomas G.; Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004,431(7005),200-205","journal-title":"Nature"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.1199484","volume":"332","author":"Yu Y.","year":"2011","unstructured":"Yu Y.; Yoon S.O.; Poulogiannis G.; Yang Q.; Ma X.M.; Vill&#xE9;n J.; Kubica N.; Hoffman G.R.; Cantley L.C.; Gygi S.P.; Blenis J.; Phosphoproteomic analysis identifies grb10 as an mtorc1 substrate that negatively regulates insulin signaling. Science 2011,332,1322-1326","journal-title":"Science"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1074\/jbc.M412179200","volume":"280","author":"Briaud I.","year":"2005","unstructured":"Briaud I.; Dickson L.M.; Lingohr M.K.; McCuaig J.F.; Lawrence J.C.; Rhodes C.J.; Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in &#x3B2;-cells. J Biol Chem 2005,280(3),2282-2293","journal-title":"J Biol Chem"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"Sarbassov D.D.","year":"2005","unstructured":"Sarbassov D.D.; Guertin D.A.; Ali S.M.; Sabatini D.M.; Phosphorylation and regulation of Akt\/PKB by the rictor-MTOR complex. Science 2005,307,1098-1101","journal-title":"Science"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"9902","DOI":"10.1073\/pnas.0811321106","volume":"106","author":"Cybulski N.","year":"2009","unstructured":"Cybulski N.; Polak P.; Auwerx J.; R&#xFC;egg M.A.; Hall M.N.; mTOR complex 2 in adipose tissue negatively controls whole-body growth. Proc Natl Acad Sci 2009,106(24),9902-9907","journal-title":"Proc Natl Acad Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2337\/db09-1061","volume":"59","author":"Kumar A.","year":"2010","unstructured":"Kumar A.; Lawrence J.C.; Jung D.Y.; Ko H.J.; Keller S.R.; Kim J.K.; Magnuson M.A.; Harris T.E.; Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes 2010,59(6),1397-1406","journal-title":"Diabetes"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.molcel.2012.09.029","volume":"48","author":"Kim S.J.","year":"2012","unstructured":"Kim S.J.; DeStefano M.A.; Oh W.J.; Wu C.; Vega-Cotto N.M.; Finlan M.; Liu D.; Su B.; Jacinto E.; mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8. Mol Cell 2012,48(6),875-887","journal-title":"Mol Cell"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"7832","DOI":"10.1074\/jbc.M807458200","volume":"284","author":"Balcazar N.","year":"2009","unstructured":"Balcazar N.; Sathyamurthy A.; Elghazi L.; Gould A.; Weiss A.; Shiojima I.; Walsh K.; Bernal-Mizrachi E.; mTORC1 activation regulates &#x3B2;-cell mass and proliferation by modulation of cyclin D2 synthesis and stability. J Biol Chem 2009,284(12),7832-7842","journal-title":"J Biol Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.2337\/db08-0519","volume":"58","author":"Hamada S.","year":"2009","unstructured":"Hamada S.; Hara K.; Hamada T.; Yasuda H.; Moriyama H.; Nakayama R.; Nagata M.; Yokono K.; Upregulation of the mammalian target of rapamycin complex 1 pathway by Ras homolog enriched in brain in pancreatic &#x3B2;-cells leads to increased &#x3B2;-cell mass and prevention of hyperglycemia. Diabetes 2009,58(6),1321-1332","journal-title":"Diabetes"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"9250","DOI":"10.1073\/pnas.0803047105","volume":"105","author":"Rachdi L.","year":"2008","unstructured":"Rachdi L.; Balcazar N.; Osorio-Duque F.; Elghazi L.; Weiss A.; Gould A.; Chang-Chen K.J.; Gambello M.J.; Bernal-Mizrachi E.; Disruption of Tsc2 in pancreatic &#x3B2; cells induces &#x3B2; cell mass expansion and improved glucose tolerance in a TORC1-dependent manner. Proc Natl Acad Sci 2008,105(27),9250-9255","journal-title":"Proc Natl Acad Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"15755","DOI":"10.1038\/ncomms15755","volume":"8","author":"Ni Q.","year":"2017","unstructured":"Ni Q.; Gu Y.; Xie Y.; Yin Q.; Zhang H.; Nie A.; Li W.; Wang Y.; Ning G.; Wang W.; Wang Q.; Raptor regulates functional maturation of murine beta cells. Nat Commun 2017,8(1),15755","journal-title":"Nat Commun"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cmet.2017.11.004","volume":"27","author":"Ardestani A.","year":"2018","unstructured":"Ardestani A.; Lupse B.; Kido Y.; Leibowitz G.; Maedler K.; mTORC1 signaling: A double-edged sword in diabetic &#x3B2; cells. Cell Metab 2018,27(2),314-331","journal-title":"Cell Metab"},{"key":"ref=25","first-page":"298","volume":"4","author":"Leahy J.L.","year":"1996","unstructured":"Leahy J.L.; Impaired &#x3B2;-cellfunction with chronic hyperglycemia: &#x201C;Overworked &#x3B2;-cell&#x201D; hypothesis. Diabetes Rev 1996,4,298-319","journal-title":"Diabetes Rev"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1128\/MCB.00735-09","volume":"29","author":"Dibble C.C.","year":"2009","unstructured":"Dibble C.C.; Asara J.M.; Manning B.D.; Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol Cell Biol 2009,29(21),5657-5670","journal-title":"Mol Cell Biol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/ncb2860","volume":"15","author":"Liu P.","year":"2013","unstructured":"Liu P.; Gan W.; Inuzuka H.; Lazorchak A.S.; Gao D.; Arojo O.; Liu D.; Wan L.; Zhai B.; Yu Y.; Yuan M.; Kim B.M.; Shaik S.; Menon S.; Gygi S.P.; Lee T.H.; Asara J.M.; Manning B.D.; Blenis J.; Su B.; Wei W.; Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nat Cell Biol 2013,15(11),1340-1350","journal-title":"Nat Cell Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1128\/MCB.00601-09","volume":"30","author":"Julien L.A.","year":"2010","unstructured":"Julien L.A.; Carriere A.; Moreau J.; Roux P.P.; mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. Mol Cell Biol 2010,30(4),908-921","journal-title":"Mol Cell Biol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s00125-016-4188-9","volume":"60","author":"Yuan T.","year":"2017","unstructured":"Yuan T.; Rafizadeh S.; Gorrepati K.D.D.; Lupse B.; Oberholzer J.; Maedler K.; Ardestani A.; Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes. Diabetologia 2017,60(4),668-678","journal-title":"Diabetologia"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mce.2015.07.023","volume":"414","author":"Yang Z.","year":"2015","unstructured":"Yang Z.; Liu F.; Qu H.; Wang H.; Xiao X.; Deng H.; 1, 25(OH)2D3 protects &#x3B2; cell against high glucose-induced apoptosis through mTOR suppressing. Mol Cell Endocrinol 2015,414,111-119","journal-title":"Mol Cell Endocrinol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"Jia G.","year":"2018","unstructured":"Jia G.; Hill M.A.; Sowers J.R.; Diabetic cardiomyopathy. Circ Res 2018,122(4),624-638","journal-title":"Circ Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"Yancy C.W.","year":"2013","unstructured":"Yancy C.W.; Jessup M.; Bozkurt B.; Butler J.; Casey D.E.; Drazner M.H.; Fonarow G.C.; Geraci S.A.; Horwich T.; Januzzi J.L.; Johnson M.R.; Kasper E.K.; Levy W.C.; Masoudi F.A.; McBride P.E.; McMurray J.J.V.; Mitchell J.E.; Peterson P.N.; Riegel B.; Sam F.; Stevenson L.W.; Tang W.H.W.; Tsai E.J.; Wilkoff B.L.; 2013 ACCF\/AHA guideline for the management of heart failure. J Am Coll Cardiol 2013,62(16),e147-e239","journal-title":"J Am Coll Cardiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"Rubler S.","year":"1972","unstructured":"Rubler S.; Dlugash J.; Yuceoglu Y.Z.; Kumral T.; Branwood A.W.; Grishman A.; New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972,30(6),595-602","journal-title":"Am J Cardiol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"Jia G.","year":"2016","unstructured":"Jia G.; DeMarco V.G.; Sowers J.R.; Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol 2016,12(3),144-153","journal-title":"Nat Rev Endocrinol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/CIRCRESAHA.114.302022","volume":"114","author":"Sciarretta S.","year":"2014","unstructured":"Sciarretta S.; Volpe M.; Sadoshima J.; Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res 2014,114(3),549-564","journal-title":"Circ Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"e54221","DOI":"10.1371\/journal.pone.0054221","volume":"8","author":"Zhu Y.","year":"2013","unstructured":"Zhu Y.; Pires K.M.P.; Whitehead K.J.; Olsen C.D.; Wayment B.; Zhang Y.C.; Bugger H.; Ilkun O.; Litwin S.E.; Thomas G.; Kozma S.C.; Abel E.D.; Mechanistic target of rapamycin (Mtor) is essential for murine embryonic heart development and growth. PLoS One 2013,8(1),e54221","journal-title":"PLoS One"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1042\/CS20171167","volume":"131","author":"Wu Q.Q.","year":"2017","unstructured":"Wu Q.Q.; Xiao Y.; Yuan Y.; Ma Z.G.; Liao H.H.; Liu C.; Zhu J.X.; Yang Z.; Deng W.; Tang Q.; Mechanisms contributing to cardiac remodelling. Clin Sci 2017,131(18),2319-2345","journal-title":"Clin Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"Levine B.","year":"2008","unstructured":"Levine B.; Kroemer G.; Autophagy in the pathogenesis of disease. Cell 2008,132(1),27-42","journal-title":"Cell"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"Kim J.","year":"2011","unstructured":"Kim J.; Kundu M.; Viollet B.; Guan K.L.; AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011,13(2),132-141","journal-title":"Nat Cell Biol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1091\/mbc.e08-12-1248","volume":"20","author":"Hosokawa N.","year":"2009","unstructured":"Hosokawa N.; Hara T.; Kaizuka T.; Kishi C.; Takamura A.; Miura Y.; Iemura S.; Natsume T.; Takehana K.; Yamada N.; Guan J.L.; Oshiro N.; Mizushima N.; Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 2009,20(7),1981-1991","journal-title":"Mol Biol Cell"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"Inoki K.","year":"2003","unstructured":"Inoki K.; Zhu T.; Guan K.L.; TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003,115(5),577-590","journal-title":"Cell"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"Gwinn D.M.","year":"2008","unstructured":"Gwinn D.M.; Shackelford D.B.; Egan D.F.; Mihaylova M.M.; Mery A.; Vasquez D.S.; Turk B.E.; Shaw R.J.; AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008,30(2),214-226","journal-title":"Mol Cell"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.bbadis.2013.03.013","volume":"1832","author":"Guo R.","year":"2013","unstructured":"Guo R.; Zhang Y.; Turdi S.; Ren J.; Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: Role of autophagy. Biochim Biophys Acta Mol Basis Dis 2013,1832(8),1136-1148","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.mce.2017.03.029","volume":"448","author":"Zhang Y.","year":"2017","unstructured":"Zhang Y.; Ling Y.; Yang L.; Cheng Y.; Yang P.; Song X.; Tang H.; Zhong Y.; Tang L.; He S.; Yang S.; Chen A.; Wang X.; Liraglutide relieves myocardial damage by promoting autophagy via AMPK-mTOR signaling pathway in Zucker diabetic fatty rat. Mol Cell Endocrinol 2017,448,98-107","journal-title":"Mol Cell Endocrinol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.yjmcc.2018.10.004","volume":"124","author":"Yao Q.","year":"2018","unstructured":"Yao Q.; Ke Z.; Guo S.; Yang X.; Zhang F.; Liu X.; Chen X.; Chen H.; Ke H.; Liu C.; Curcumin protects against diabetic cardiomyopathy by promoting autophagy and alleviating apoptosis. J Mol Cell Cardiol 2018,124,26-34","journal-title":"J Mol Cell Cardiol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/emmm.201303183","volume":"6","author":"V&#xF6;lkers M.","year":"2014","unstructured":"V&#xF6;lkers M.; Doroudgar S.; Nguyen N.; Konstandin M.H.; Quijada P.; Din S.; Ornelas L.; Thuerauf D.J.; Gude N.; Friedrich K.; Herzig S.; Glembotski C.C.; Sussman M.A.; PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity. EMBO Mol Med 2014,6(1),57-65","journal-title":"EMBO Mol Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2337\/diacare.28.1.164","volume":"28","author":"Gross J.L.","year":"2005","unstructured":"Gross J.L.; de Azevedo M.J.; Silveiro S.P.; Canani L.H.; Caramori M.L.; Zelmanovitz T.; Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care 2005,28(1),164-176","journal-title":"Diabetes Care"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/IJNRD.S40172","volume":"7","author":"Lim A.","year":"2014","unstructured":"Lim A.; Diabetic nephropathy - complications and treatment. Int J Nephrol Renovasc Dis 2014,7,361-381","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1681\/ASN.2008111186","volume":"20","author":"Lieberthal W.","year":"2009","unstructured":"Lieberthal W.; Levine J.S.; The role of the mammalian target of rapamycin (mTOR) in renal disease. J Am Soc Nephrol 2009,20(12),2493-2502","journal-title":"J Am Soc Nephrol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.tem.2016.07.002","volume":"27","author":"Gnudi L.","year":"2016","unstructured":"Gnudi L.; Coward R.J.M.; Long D.A.; Diabetic nephropathy: Perspective on novel molecular mechanisms. Trends Endocrinol Metab 2016,27(11),820-830","journal-title":"Trends Endocrinol Metab"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"s79","DOI":"10.2337\/diacare.27.2007.S79","volume":"27","author":"Molitch M.E.","year":"2004","unstructured":"Molitch M.E.; DeFronzo R.A.; Franz M.J.; Keane W.F.; Mogensen C.E.; Parving H.H.; Steffes M.W.; Nephropathy in diabetes. Diabetes Care 2004,27(S1),s79-s83","journal-title":"Diabetes Care"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.bbrc.2009.04.136","volume":"384","author":"Mori H.","year":"2009","unstructured":"Mori H.; Inoki K.; Masutani K.; Wakabayashi Y.; Komai K.; Nakagawa R.; Guan K.L.; Yoshimura A.; The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem Biophys Res Commun 2009,384(4),471-475","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.semnephrol.2013.11.003","volume":"34","author":"Kume S.","year":"2014","unstructured":"Kume S.; Yamahara K.; Yasuda M.; Maegawa H.; Koya D.; Autophagy: Emerging therapeutic target for diabetic nephropathy. In: Proceedings of the Seminars in nephrology Elsevier 2014,34,9-16","journal-title":"In: Proceedings of the Seminars in nephrology Elsevier"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1172\/JCI44771","volume":"121","author":"Inoki K.","year":"2011","unstructured":"Inoki K.; Mori H.; Wang J.; Suzuki T.; Hong S.; Yoshida S.; Blattner S.M.; Ikenoue T.; R&#xFC;egg M.A.; Hall M.N.; Kwiatkowski D.J.; Rastaldi M.P.; Huber T.B.; Kretzler M.; Holzman L.B.; Wiggins R.C.; Guan K.L.; mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest 2011,121(6),2181-2196","journal-title":"J Clin Invest"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1681\/ASN.2012111080","volume":"24","author":"Yamahara K.","year":"2013","unstructured":"Yamahara K.; Kume S.; Koya D.; Tanaka Y.; Morita Y.; Chin-Kanasaki M.; Araki H.; Isshiki K.; Araki S.; Haneda M.; Matsusaka T.; Kashiwagi A.; Maegawa H.; Uzu T.; Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions. J Am Soc Nephrol 2013,24(11),1769-1781","journal-title":"J Am Soc Nephrol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11892-017-0879-y","volume":"17","author":"Kitada M.","year":"2017","unstructured":"Kitada M.; Ogura Y.; Monno I.; Koya D.; Regulating autophagy as a therapeutic target for diabetic nephropathy. Curr Diab Rep 2017,17(7),53","journal-title":"Curr Diab Rep"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3389\/fphar.2018.00443","volume":"9","author":"Wu W.","year":"2018","unstructured":"Wu W.; Hu W.; Han W.B.; Liu Y.L.; Tu Y.; Yang H.M.; Fang Q.J.; Zhou M.Y.; Wan Z.Y.; Tang R.M.; Tang H.T.; Wan Y.G.; Inhibition of Akt\/mTOR\/p70S6K signaling activity with huangkui capsule alleviates the early glomerular pathological changes in diabetic nephropathy. Front Pharmacol 2018,9,443","journal-title":"Front Pharmacol"},{"key":"ref=58","unstructured":"International Diabetes Federation - Eye health Available from: https:\/\/idf.org\/our-activities\/care-prevention\/eye-health.html"},{"key":"ref=59","year":"2019","unstructured":"International Diabetes Federation - World Sight DayAvailable from: 2019"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/sj.eye.6700133","volume":"16","author":"Cai J.","year":"2002","unstructured":"Cai J.; Boulton M.; The pathogenesis of diabetic retinopathy: Old concepts and new questions. Eye 2002,16(3),242-260","journal-title":"Eye"},{"key":"ref=61","first-page":"1","volume":"2","author":"Wong T.Y.","year":"2016","unstructured":"Wong T.Y.; Cheung C.M.G.; Larsen M.; Sharma S.; Sim&#xF3; R.; Diabetic retinopathy. Nat Rev Dis Primers 2016,2(1),1","journal-title":"Nat Rev Dis Primers"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"Wilkinson C.P.","year":"2003","unstructured":"Wilkinson C.P.; Ferris F.L.; Klein R.E.; Lee P.P.; Agardh C.D.; Davis M.; Dills D.; Kampik A.; Pararajasegaram R.; Verdaguer J.T.; Lum F.; Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003,110(9),1677-1682","journal-title":"Ophthalmology"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"Brownlee M.","year":"2001","unstructured":"Brownlee M.; Biochemistry and molecular cell biology of diabetic complications. Nature 2001,414(6865),813-820","journal-title":"Nature"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tem.2013.09.005","volume":"25","author":"Sim&#xF3; R.","year":"2014","unstructured":"Sim&#xF3; R.; Hern&#xE1;ndez C.; Neurodegeneration in the diabetic eye: New insights and therapeutic perspectives. Trends Endocrinol Metab 2014,25(1),23-33","journal-title":"Trends Endocrinol Metab"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","volume":"30","author":"Tang J.","year":"2011","unstructured":"Tang J.; Kern T.S.; Inflammation in diabetic retinopathy. Prog Retin Eye Res 2011,30(5),343-358","journal-title":"Prog Retin Eye Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.peptides.2012.04.008","volume":"36","author":"Wilkinson-Berka J.L.","year":"2012","unstructured":"Wilkinson-Berka J.L.; Agrotis A.; Deliyanti D.; The retinal renin-angiotensin system: Roles of angiotensin II and aldosterone. Peptides 2012,36(1),142-150","journal-title":"Peptides"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1096\/fj.01-0658com","volume":"16","author":"Humar R.","year":"2002","unstructured":"Humar R.; Kiefer F.N.; Berns H.; Resink T.J.; Battegay E.J.; Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR) \u2010dependent signaling. FASEB J 2002,16(8),771-780","journal-title":"FASEB J"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e964","DOI":"10.1038\/cddis.2013.506","volume":"4","author":"Blagosklonny M.V.","year":"2013","unstructured":"Blagosklonny M.V.; TOR-centric view on insulin resistance and diabetic complications: Perspective for endocrinologists and gerontologists. Cell Death Dis 2013,4(12),e964-e964","journal-title":"Cell Death Dis"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/589813","volume":"2011","author":"Jacot J.L.","year":"2011","unstructured":"Jacot J.L.; Sherris D.; Potential therapeutic roles for inhibition of the pi3k\/akt\/mtor pathway in the pathophysiology of diabetic retinopathy. J Ophthalmol 2011,2011,1-19","journal-title":"J Ophthalmol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1172\/JCI0213776","volume":"109","author":"Poulaki V.","year":"2002","unstructured":"Poulaki V.; Qin W.; Joussen A.M.; Hurlbut P.; Wiegand S.J.; Rudge J.; Yancopoulos G.D.; Adamis A.P.; Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1&#x3B1; and VEGF. J Clin Invest 2002,109(6),805-815","journal-title":"J Clin Invest"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1159\/000453207","volume":"40","author":"Wei J.","year":"2016","unstructured":"Wei J.; Jiang H.; Gao H.; Wang G.; Blocking mammalian target of rapamycin (mTOR) attenuates HIF-1&#x3B1; pathways engaged-vascular endothelial growth factor (VEGF) in Diabetic Retinopathy. Cell Physiol Biochem 2016,40(6),1570-1577","journal-title":"Cell Physiol Biochem"},{"key":"ref=72","first-page":"3569","volume":"23","author":"Zhao B.W.","year":"2019","unstructured":"Zhao B.W.; Dai H.Y.; Hao L.N.; Liu Y.W.; MiR-29 regulates retinopathy in diabetic mice via the AMPK signaling pathway. Eur Rev Med Pharmacol Sci 2019,23(9),3569-3574","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.biopha.2018.09.140","volume":"108","author":"Chen H.","year":"2018","unstructured":"Chen H.; Ji Y.; Yan X.; Su G.; Chen L.; Xiao J.; Berberine attenuates apoptosis in rat retinal M&#xFC;ller cells stimulated with high glucose via enhancing autophagy and the AMPK\/mTOR signaling. Biomed Pharmacother 2018,108,1201-1207","journal-title":"Biomed Pharmacother"},{"key":"ref=74","first-page":"1024","volume":"19","author":"Ran Z.","year":"2019","unstructured":"Ran Z.; Zhang Y.; Wen X.; Ma J.; Curcumin inhibits high glucose induced inflammatory injury in human retinal pigment epithelial cells through the ROS PI3K\/AKT\/mTOR signaling pathway. Mol Med Rep 2019,19(2),1024-1031","journal-title":"Mol Med Rep"}],"container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1874467215666221005123919","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/209609\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1874467215666221005123919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:58:17Z","timestamp":1746572297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/209609\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874467215666221005123919","relation":{},"ISSN":["1874-4672"],"issn-type":[{"value":"1874-4672","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e051022209609"}}